Normalized claim
Accuracy: 96%
Achieved 96% accuracy in cancer predisposition prediction
Last evidence check: Jul 22, 2026
Mayo Clinic collaborates on AI-driven imaging and genomics
Use case typeMedical imagingUpdated Jun 13, 2026
Mayo Clinic collaborates with Microsoft Research and Cerebras Systems to advance diagnostics and treatment planning in radiology and genomics. The project leverages generative AI with medical-specific foundation models, integrating radiology images and genomic sequencing data. Applications include automating chest X-ray reports and analyzing genomic data for disease prediction and treatment optimization. Specific achievements include an accuracy of 96% in cancer predisposition prediction, 83% in cardiovascular risk, and 87% in rheumatoid arthritis drug response prediction.
- Organization
- Mayo Clinic
- Industry
- Healthcare
- Location
- United States
- Published
- January 2025
Why do we believe this?Outcome claims, sources, and evidence checks
Normalized claim
Accuracy: 83%
Achieved 83% accuracy in cardiovascular risk prediction
Last evidence check: Jul 22, 2026
Normalized claim
Accuracy: 87%
Reached 87% accuracy in rheumatoid arthritis drug response prediction
Last evidence check: Jul 22, 2026
Why do we believe this deployment?Customer identity, provider attribution, maturity, and source checks
- Customer
- Mayo Clinic
- Provider
- Microsoft
- Maturity
- Unknown
- Linked source
- biopharmatrend.com
No explicit deployment-stage evidence found.
Customer identity supportedSource describes one deploymentMaturity evidence evaluated
Primary read
Use case focus
Showing 3 of 5
- 1Automated Chest X-ray Report Generation Agent
- 2Genomic Data Analysis for Disease Risk Prediction
- 3AI-driven Treatment Response Prediction for Rheumatoid Arthritis
- Developed generative AI foundation models combining radiology images and genomic sequencing data
- Automated chest X-ray report generation using AI-driven tools
- Utilized Cerebras Wafer Scale Engine to power large-scale genomic model training
- Enabled real-time analysis and prediction from genomic data
Technologies
Sources & evidence2
Evidence: Medium45/100Evidence strength
- Customer explicitly identified
- Quantified outcome available
- Multiple corroborating sources available
- Recent evidence check available
- Last evidence check: Jul 22, 2026.
ExpandedExpanded
The same organization appears in newer AI deployment evidence.
- Same organization re-documented as recently as 2026.
- Cited source last checked Jun 12, 2026 — ok (0/2 broken).
Measures whether this deployment's public evidence persists — not whether the system is still in production.
Published: Jan 18, 2025Publisher: biopharmatrend.com
AI-generated summary. Verify important details with the linked sources before relying on this case.
Explore related AI use cases
Customer evidence
Provider evidence
AI patterns
Browse the catalog
Was this useful?
Community
Comments
No published comments yet.